We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It's a free option for AZN to hold on to their shares.....wouldn't be surprised if they monitor how Niox develops and then bid for the rest of the company...expect shares to return to 30p+ now it's a cleaner and leaner business...management must have high conviction on Niox working otherwise they wouldn't have gone all in. Throw in the prospect of a large US settlement on Lungfit and it's looking rosy. Also, the lack of a trading update means all is well as they would have to inform market if any material change...
Yup, I sold a few at about 24 as it’s not the direction of travel I was expecting. Left a modest holding in to see what the company can do from here when it’s debt free. Feel a bit disappointed as I held from 18 to 30 without selling, but it’s a bigger return than I would have got in a Bank I guess.
cashfornuthin , think they would have to or it would crush the SP if they sold. AZN was the reason i invested here . Really disappointed as this was going to be my LTH.
Azn are keeping there shareholding.
that's what i thought..
not sure how anyone could take this kind of news in this type of market as negative...
No debt is terrific news but they have given up on the drugs i was invested here for so im out. Good luck folks .
Yup, good reaction from the market so far.
Seems to be.
overall pretty neutral / slightly positive - means we will be completely debt free - with a portfolio of a good strong revenue generating product in a growing market , cash generative and c £14m cash in hand.
the two astrazeneca drugs looked pretty cash consuming , so removes a bit of a drain of resources.
would have been nice to see some clarity on lungfit but interesting that they mention it as one of their products with US marketing rights still - i cannot see them loosing this claim without settling for a large pay out - for a minimum of what we paid .... that wuld support the sp itself nearly.
overall net positive i think-